Chem. J. Chinese Universities ›› 2014, Vol. 35 ›› Issue (5): 959.doi: 10.7503/cjcu20131054

• Organic Chemistry • Previous Articles     Next Articles

Stereospecific Synthesis of ω-Amino-β-D-furanoribosyl cetic Acid Based on Microwave Assisted ittig-Michael Tandem Reaction

MA Donglai1, LI Xiaoliu1,*(), HAO Le1, ZHANG Pingzhu1, CHEN Hua1, ZHAO Ying2   

  1. 1. Key Laboratory of Chemical Biology of Hebei Province, School of Chemistry and nvironmental Science, Hebei University, Baoding 071002, China
    2. College of Science, Agricultural University of Hebei, Baoding 071001, China
  • Received:2013-10-29 Online:2014-05-10 Published:2014-04-12
  • Contact: LI Xiaoliu E-mail:lixl@hbu.cn
  • Supported by:
    † Supported by the National Natural Science Foundation of China(Nos.21172051, 21372060), the Key Basic Research Foundation of Hebei Province, China(No.12966417D) and the Natural Science Foundation of Hebei Province, China(Nos.Y2011119, ZH2011110) and the Medicinal Joint Founds of the Natural Science Foundation of Hebei Province and Shijiazhuang Pharmaceutical Group Foundation of China(Nos.B2011201169, B2012201113)

Abstract:

An efficient and stereoselective method for synthesizing ω-amino-β-D-furanoribosylactic ester was established based on the microwave assisted Wittig-Michael tandem reaction of acetone protection of D-ribose(2) and Ylide 3(Ph3P═CHCOOEt), and followed by ω-azidation and reduction. The microwave assisted Wittig-Michael addition reaction was carried out effectively and β-stereoselectively in CH3CN at 115 ℃ with a yield up to 91% within 10 min, and the α-stereomer could easily converted to the thermodynamically more stable β-stereomer during workup in basic condition. The calculation results of quantum chemistry show that β-isomer 4b is higher than α-isomer 4a in thermodynamic stability. The structures of the compounds were identified by spectral analyses of 1H NMR, 13C NMR and HRMS.

Key words: Amino furanoribosyl acid ester, Microwave assisted reaction, Wittig-Michael tandem reaction

CLC Number: 

TrendMD: